Patents by Inventor Min Jae Cho
Min Jae Cho has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11840204Abstract: A cleaner for a lidar sensor may include: a blast pipe unit through which wind generated from a fan of an engine passes; and a lidar sensor installed in the blast pipe unit, wherein foreign matter adhering to the surface of the lidar sensor are removed by wind discharged from the blast pipe unit.Type: GrantFiled: May 1, 2019Date of Patent: December 12, 2023Assignee: Hyundai Mobis Co., Ltd.Inventors: Kyung Rin Kim, Sung Eun Jo, Won Gyum Kim, Young Shin Kim, Min Jae Cho
-
Patent number: 11550053Abstract: A object detection apparatus may include: an object detection sensor having a cover for protecting the object detection sensor from foreign matter, and configured to sense a target object by transmitting a scan signal to the target object and receiving a sensing signal reflected from the target object; a protection film part including a protection film disposed on an outer surface of the cover to prevent contamination of the cover by foreign matter; and a control unit configured to replace the protection film disposed on the outer surface of the cover through a winding operation for the protection film part when a protection film replacement condition is satisfied due to contamination of the protection film, in order to prevent a reduction in sensing performance of the object detection sensor due to contamination by foreign matter.Type: GrantFiled: May 14, 2019Date of Patent: January 10, 2023Assignee: Hyundai Mobis Co., Ltd.Inventors: Kyung Rin Kim, Sung Eun Jo, Won Gyum Kim, Young Shin Kim, Min Jae Cho
-
Patent number: 10981917Abstract: The present invention relates to a heterocyclic compound represented by Chemical Formula 1 that can be used for the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: GrantFiled: February 7, 2018Date of Patent: April 20, 2021Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Bong-Yong Lee, Min-Jae Cho, Hyung-Geun Lee, Myung-gi Jung, Yunju Oh
-
Patent number: 10649256Abstract: A panel module including a display panel, a chips-on-film (COF) having a first end connected to an end portion of the display panel, and a COF cover configured to extend past the first end of the COF to block the first end of the COF, the cover having a front surface formed to be coplanar with a front surface of the display panel.Type: GrantFiled: December 22, 2017Date of Patent: May 12, 2020Assignee: SAMSUNG ELECTRONICS CO., LTD.Inventors: Min Jae Cho, Myeong Gil Kim, Seo Joon Lee, Hyun Jun Jung, Jong Hee Han
-
Publication number: 20190359617Abstract: The present invention relates to a heterocyclic compound represented by Chemical Formula 1 that can be used for the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: ApplicationFiled: February 7, 2018Publication date: November 28, 2019Inventors: Bong-Yong Lee, Min-Jae Cho, Hyung-Geun Lee, Myung-gi Jung, Yunju Oh
-
Publication number: 20190351879Abstract: A cleaner for a lidar sensor may include: a blast pipe unit through which wind generated from a fan of an engine passes; and a lidar sensor installed in the blast pipe unit, wherein foreign matter adhering to the surface of the lidar sensor are removed by wind discharged from the blast pipe unit.Type: ApplicationFiled: May 1, 2019Publication date: November 21, 2019Inventors: Kyung Rin Kim, Sung Eun Jo, Won Gyum Kim, Young Shin Kim, Min Jae Cho
-
Publication number: 20190353785Abstract: A object detection apparatus may include: an object detection sensor having a cover for protecting the object detection sensor from foreign matter, and configured to sense a target object by transmitting a scan signal to the target object and receiving a sensing signal reflected from the target object; a protection film part including a protection film disposed on an outer surface of the cover to prevent contamination of the cover by foreign matter; and a control unit configured to replace the protection film disposed on the outer surface of the cover through a winding operation for the protection film part when a protection film replacement condition is satisfied due to contamination of the protection film, in order to prevent a reduction in sensing performance of the object detection sensor due to contamination by foreign matter.Type: ApplicationFiled: May 14, 2019Publication date: November 21, 2019Inventors: Kyung Rin Kim, Sung Eun Jo, Won Gyum Kim, Young Shin Kim, Min Jae Cho
-
Patent number: 10081634Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: GrantFiled: June 23, 2015Date of Patent: September 25, 2018Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Yong Lee Bong
-
Patent number: 10011586Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: GrantFiled: June 7, 2016Date of Patent: July 3, 2018Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Bong Yong Lee
-
Publication number: 20180180930Abstract: A panel module including a display panel, a chips-on-film (COF) having a first end connected to an end portion of the display panel, and a COF cover configured to extend past the first end of the COF to block the first end of the COF, the cover having a front surface formed to be coplanar with a front surface of the display panel.Type: ApplicationFiled: December 22, 2017Publication date: June 28, 2018Applicant: SAMSUNG ELECTRONICS CO., LTD.Inventors: Min Jae CHO, Myeong Gil KIM, Seo Joon LEE, Hyun Jun JUNG, Jong Hee HAN
-
Publication number: 20180044322Abstract: The present invention relates to a heterocyclic compound having a novel structure that can be used in the prevention or treatment of diseases caused by abnormality in a PRS (prolyl-tRNA synthetase) activity, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: ApplicationFiled: June 7, 2016Publication date: February 15, 2018Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Bong Yong Lee
-
Patent number: 9617216Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.Type: GrantFiled: October 21, 2014Date of Patent: April 11, 2017Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Joon Seok Park, Youn Jung Yoon, Chang Min Park, Yun Soo Na, Min Jae Cho, Ho Bin Lee, Mi Ryeong Han, Yeon Jung Park, Ji Duck Kim
-
Publication number: 20170088551Abstract: The present invention relates to a compound represented by chemical formula 1, which can be used for the prevention and treatment of diseases caused by abnormality in a prolyl-tRNA synthetase (PRS) activity, or a pharmaceutically acceptable salt thereof, a method for preparing the same, and a pharmaceutical composition comprising the same.Type: ApplicationFiled: June 23, 2015Publication date: March 30, 2017Applicant: Daewoong Pharmaceutical., Ltd.Inventors: Joon Seok Park, Youn Jung Yoon, Min Jae Cho, Ho Bin Lee, Ja Kyung Yoo, Yong Lee Bong
-
Publication number: 20160304460Abstract: The present invention relates to novel oxodihydropyridinecarbohydrazide derivatives with excellent antifungal activities, an antifungal composition containing the same, and its use for the prevention and treatment of fungal infectious diseases. The oxodihydropyridinecarbohydrazide derivatives of the present invention have excellent antifungal and fungicidal activities, and thus will be useful for the prevention and treatment of various fungal infections by Candida spp., Aspergillus spp., Cryptococcus neoformans and Trichophyton spp., etc. Additionally, the oxodihydropyridinecarbohydrazide derivatives of the present invention, unlike other fungicidal preparations, can be orally administered.Type: ApplicationFiled: October 21, 2014Publication date: October 20, 2016Applicant: DAEWOONG PHARMACEUTICAL CO., LTD.Inventors: Joon Seok Park, Youn Jung Yoon, Chang Min Park, Yun Soo Na, Min Jae Cho, Ho Bin Lee, Mi Ryeong Han, Yeon Jung Park, Ji Duck Kim
-
Patent number: 9376429Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).Type: GrantFiled: October 15, 2013Date of Patent: June 28, 2016Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ha Young Kim, In Woo Kim, Sun Ah Jun, Yun Soo Na, Hyung Geun Lee, Min Jae Cho, Jun Hee Lee, Hyo Shin Kim, Yun Soo Yoon, Kyung Ha Chung, Ji Duck Kim
-
Publication number: 20150336944Abstract: The present invention relates to a compound having a blocking effect against sodium ion channels, particularly Nav1.7, a preparation method thereof and the use thereof. A compound represented by formula 1 according to the invention, or a pharmaceutically acceptable salt, hydrate, solvate or isomer thereof may be effectively used for the prevention or treatment of pain, for example, acute pain, chronic pain, neuropathic pain, post-surgery pain, migraine, arthralgia, neuropathy, nerve injury, diabetic neuropathy, neuropathic disease, epilepsy, arrhythmia, myotonia, ataxia, multiple sclerosis, irritable bowel syndrome, urinary incontinence, visceral pain, depression, erythromelalgia, or paroxysmal extreme pain disorder (PEPD).Type: ApplicationFiled: October 15, 2013Publication date: November 26, 2015Inventors: Ha Young Kim, In Woo Kim, Sun Ah Jun, Yun Soo Na, Hyung Geun Lee, Min Jae Cho, Jun Hee Lee, Hyo Shin Kim, Yun Soo Yoon, Kyung Ha Chung, Ji Duck Kim
-
Patent number: 8362012Abstract: The present invention relates to a novel benzoxazine benzimidazole derivative of formula (1) as an antagonist against a vanilloid receptor-1, a pharmaceutical composition comprising the same as an active ingredient, and a use thereof. The benzoxazine benzimidazole derivative of the present invention may be useful for preventing or treating a disease associated with antagonistic activity of vanilloid receptor-1: wherein, R1, R2, R3, R3?, Q1, Q2, Q3 and Q4 have same meanings as defined in the specification.Type: GrantFiled: April 16, 2009Date of Patent: January 29, 2013Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ji Duck Kim, Hong-Chul Yoon, Seong Hee Cho, Inwoo Kim, Min Jae Cho, In Young Lee, Hyae Jung Hyun, Eunkyung Park
-
Patent number: 8026235Abstract: Discloses is a benzoxazine benzimidazole derivative, represented by Chemical Formula 1, functioning as an antagonist to the vanilloid receptor-1, a pharmaceutical composition comprising the same, and the use thereof. The benzoxazine benzimidazole derivative can be useful for preventing or treating a disease associated with antagonistic activity of vanilloid receptor-1, without hyperthermia: wherein, R1, R2, R3, R4 and R5 are as defined in the specification.Type: GrantFiled: October 21, 2010Date of Patent: September 27, 2011Assignee: Daewoong Pharmaceutical Co., Ltd.Inventors: Ji Duck Kim, Hong-Chul Yoon, In Woo Kim, Min Jae Cho, In Young Lee, Sang Ho Lee, Eun Kyung Park, Kwon Jo Lim, Sang Hyun Nam
-
Publication number: 20110086849Abstract: The present invention relates to a novel benzoxazine benzimidazole derivative of formula (1) as an antagonist against a vanilloid receptor-1, a pharmaceutical composition comprising the same as an active ingredient, and a use thereof. The benzoxazine benzimidazole derivative of the present invention may be useful for preventing or treating a disease associated with antagonistic activity of vanilloid receptor-1: wherein, R1, R2, R3, R3?, Q1, Q2, Q3 and Q4 have same meanings as defined in the specification.Type: ApplicationFiled: April 16, 2009Publication date: April 14, 2011Applicant: DAEWOONG PHARMACEUTICALS CO., LTD.Inventors: Ji Duck Kim, Hong-Chul Yoon, Seong Hee Cho, Inwoo Kim, Min Jae Cho, IN Young Lee, Hyae Jung Hyun, Eunkyung Park